ClinicalTrials.govpublic full text
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
advanced head and neck squamous cell carcinoma, erbitux, cetuximab, oral cancer, oropharyngeal cancer, laryngeal cancer, head and neck squamous cell carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 884064
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.